DENNIS D KIM Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DENNIS D KIM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DENNIS D KIM. DENNIS D KIM is Chief Medical Officer in ZAFGEN, INC. ($ZFGN) and Sr. VP, Corporate Development in Orexigen Therapeutics, Inc. ($OREX) and Chief Medical Officer in Emerald Bioscience, Inc. ($NMUS).
Latest Insider Trading Transactions of DENNIS D KIM
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LRMR, OREX, NMUS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 11 2020 | NMUS | Emerald Bioscience ... | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 0.05 | 4,000,000 | 180,000 | 4,736,541 | |
Aug 23 2019 | NMUS | Emerald Bioscience ... | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 0.30 | 736,541 | 220,962 | 736,541 | |
Aug 23 2019 | NMUS | Emerald Bioscience ... | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 0.30 | 736,541 | 220,962 | 736,541 | |
Jan 24 2019 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 4.63 | 95,000 | 439,850 | 95,000 | |
Feb 23 2018 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 7.77 | 125,000 | 971,250 | 125,000 | |
Jul 12 2017 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Buy | P | 3.39 | 10,000 | 33,900 | 21,443 | 11.4 K to 21.4 K (+87.39 %) |
May 11 2017 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Buy | P | 4.40 | 9,800 | 43,120 | 11,443 | 1.6 K to 11.4 K (+596.47 %) |
May 11 2017 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Buy | P | 4.40 | 200 | 880 | 1,643 | 1.4 K to 1.6 K (+13.86 %) |
Jan 31 2017 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 4.05 | 88,000 | 356,400 | 88,000 | |
Apr 04 2016 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 6.68 | 37,500 | 250,500 | 37,500 | |
Apr 04 2016 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 6.68 | 75,000 | 501,000 | 75,000 | |
Sep 17 2015 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | M | 1.57 | 9,142 | 14,353 | 103,312 | |
Sep 17 2015 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | M | 1.57 | 30,265 | 47,516 | 112,454 | |
Sep 17 2015 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Sell | S | 40.00 | 9,142 | 365,680 | 0 | 9.1 K to 0 (-100.00 %) |
Sep 17 2015 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Buy | M | 1.57 | 9,142 | 14,353 | 9,142 | 0 to 9.1 K |
Sep 17 2015 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Sell | S | 40.00 | 30,265 | 1,210,600 | 0 | 30.3 K to 0 (-100.00 %) |
Sep 17 2015 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Buy | M | 1.57 | 30,265 | 47,516 | 30,265 | 0 to 30.3 K |
Sep 16 2015 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | M | 1.57 | 593 | 931 | 142,719 | |
Sep 16 2015 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Sell | S | 40.00 | 593 | 23,720 | 0 | 593 to 0 (-100.00 %) |
Sep 16 2015 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Buy | M | 1.57 | 593 | 931 | 593 | 0 to 593 |
Mar 03 2015 | ZFGN | ZAFGEN, INC. | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 38.65 | 90,000 | 3,478,500 | 281,509 | |
Apr 27 2009 | OREX | Orexigen Therapeut ... | KIM DENNIS D | Sr. VP, Corporate D ... | Option Exercise | A | 2.13 | 44,936 | 95,714 | 44,936 | |
Mar 26 2009 | OREX | Orexigen Therapeut ... | KIM DENNIS D | Sr. VP, Corporate D ... | Grant | A | 2.65 | 10,000 | 26,500 | 25,200 | 15.2 K to 25.2 K (+65.79 %) |
Page: 1